Allergan said Friday that it would initiate phase 3 clinical trials of Innotox, Medytox’s type A liquid botulinum product, “as soon as is reasonably possible.”

The announcement indicates that the trials for the cosmetic treatment, also known as BTX, would likely begin next year if Medytox supplies the testing batch as scheduled.
Continue reading here: